Tailored antiplatelet therapy based on individual ischemic and bleeding risk profiles can optimize treatment outcomes and minimize complications.
Absolute Event Rate: 0% vs 0%
The landscape of antiplatelet treatment regimens has significantly evolved over time, with the current trend being toward a tailored approach based on risk profile, aiming to reduce the risk of bleeding while maintaining ischemic protection. The accurate evaluation of each patient's ischemic and bleeding risk profile is of utmost importance. Dedicated tools have been developed to optimize patient risk profiling and help guide the selection of the antiplatelet regimen. Based on risk estimation, several strategies can be used to reduce the overall risk, including the selection and duration of the antiplatelet regimen.
Laudani et al. (Tue,) reported a other. Tailored antiplatelet therapy based on individual ischemic and bleeding risk profiles can optimize treatment outcomes and minimize complications.